Disorders of Bone Mineral Metabolism: Normal Homeostasis

Pediatric Endocrinology

Volumn , Issue , 2008, Pages 74-126

  Root, Allen W ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877300993     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604090-3.50008-9     Document Type: Chapter

References (259)

1. Favus MJ, Bushinsky DA, Lemann J Regulation of calcium, magnesium, and phosphate metabolism. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 76-83. American Society for Bone and Mineral Research, Washington D.C. Sixth edition. M.J. Favus (Ed.).
2. Bringhurst R, Demay MB, Kronenberg HM Hormones and disorders of mineral metabolism. Williams textbook of endocrinology 2003, 1303-1371. Saunders, Philadelphia. Tenth edition. P.R. Larsen, H.M. Kronenberg, S. Melmed, K.S. Polonsky (Eds.).
3. Williams PD, Puddey IB, Martin NG, Beilin LJ Plasma cytosolic free calcium concentration, total plasma calcium concentration and blood pressure in human twins: A genetic analysis. Clin Sci 1992, 82:493-504.
4. Dewitte K, Stockl D, Thienpont LM pH dependency of serum ionised calcium. Lancet 1999, 354:1793-1794.
5. Bushinsky DA, Monk RD Calcium. Lancet 1998, 352:306-311.
6. Gill DL, Spassova MA, Soboloff J Calcium entry signals: Trickles and torrents. Science 2006, 313:183-184.
7. Davila HM Molecular and functional diversity of voltage-gated calcium channels. Ann NY Acad Sci 1999, 868:102-117.
8. 2+ channels by calmodulin. Sci STKE 2005, 2005:re15.
9. Abernethy DR, Schwartz JB Calcium-antagonist drugs. N Engl J Med 1999, 341:1447-1457.
10. Burgess DL, Noebels JL Voltage-dependent calcium channel mutations in neurological disease. Ann NY Acad Sci 1999, 868:199-212.
11. a1B N-type calcium channel isoforms with distinct biophysical properties. Ann NY Acad Sci 1999, 868:118-130.
12. 3 receptors. Science 2006, 313:229-233.
13. 2+ entry. Science 2006, 312:1220-1223.
14. Feske S, Gwack Y, Prakriya M, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441:179-185.
15. Wong V, Goodenough DA Paracellular channels!. Science 1999, 285:62.
16. Nillus B, Voeta T, Peters J TRP channels in disease. Sci STKE 2005, 2005:re8.
17. Lanou AJ, Berkow SE, Barnard ND Calcium, dairy products, and bone health in children and young adults: A reevaluation of the evidence. Pediatrics 2005, 115:736-743.
18. Gartner LM, Greer FR Prevention of rickets and vitamin D deficiency: New guidelines for Vitamin D intake. Pediatrics 2003, 111:908-910.
19. Hollis BW Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005, 135:317-322.
20. Greer FR, Krebs NF Optimizing bone health and calcium intakes of infants, children, and adolescents. Pediatrics 2006, 117:578-585.
21. Greer FR Bone health: It's more than calcium intake. Pediatrics 2005, 115:792-794.
22. Bushinsky DA Calcium, magnesium, and phosphorus: Renal handling and urinary excretion. Primer on the metabolic bone diseases and disorders of mineral metabolism 1999, 67-74. Lippincott Williams & Wilkins, Philadelphia, . Fourth edition. M. Favus (Ed.).
23. Chang Q, Hoefs S, van der Kempt AW, et al. The beta glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005, 310:490-493.
24. Brown EM, Juppner H Parathyroid hormone: Synthesis, secretion, and action. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 90-99. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
25. Gether U Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrine Reviews 2000, 21:90-113.
26. o)-sensing receptor (CaR): Roles in cell signaling and control of diverse cellular functions. Hormones and signaling 2000, 209-253. Academic Press, New York. B.W. O'Malley (Ed.).
27. Pidasheva S, Grant M, Canaff L, et al. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: Biochemical and biophysical characterization of the CASR mutants retained intracellularly. Hum Molec Genet 2006, 15:2200-2209.
28. Friedman PA Calcium transport in the kidney. Curr Opin Nephrol Hypertension 1999, 8:589-595.
29. Cole DEC, Peltekova VD, Rubin LA, et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1999, 353:112-115.
30. Scillitani A, Guarnieri V, de Geronimo S, et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 2004, 89:5634-5638.
31. Chang W, Tu C, Chen T-H, Komuves L, et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999, 140:5883-5893.
32. Zaidi M, Adebanjo OA Calcium handling by the osteoclast. The Endocrinologist 2000, 10:155-163.
33. 2+ receptor from brain to gut: Common stimulus, diverse actions. Trends Endocrinol Metab 1998, 9:354-359.
34. 2+-sensing receptor: Molecular biology and clinical importance. Curr Opin Pediatr 1998, 10:435-440.
35. Steddon SJ, Cunningham J Calcimimetics and calcilytics: Fooling the calcium receptor. Lancet 2005, 365:2237-2239.
36. Dong BJ Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Clin Therapeutics 2005, 27:1725-1751.
37. Weisinger JR, Bellorin-Font E Magnesium and phosphorus. Lancet 1998, 352:391-396.
38. White KE, Larsson TE, Econs MJ The roles of specific genes implicated as circulating factors in normal and disordered phosphate homeostasis: Frizzled related protein-4, matric extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocrine Reviews 2006, 27:221-241.
39. Drezner MK PHEX gene and hypophosphatemia. Kid Internat 2000, 57:9-18.
40. Jan de Beur SM Tumor-induced osteomalacia. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 345-351. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
41. 3 upregulates FGF23 gene expression in bone: The final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005, 289:G1036-G1042.
42. Masuyama R, Stockmans I, Torrekens S, et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006, 116:3150-3159.
43. Yu X, Ibrahimi OA, Goetz R, et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 2005, 146:4647-4656.
44. Campos M, Couture C, Hirata IY, et al. Human recombinant PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from FGF23 and MEPE. Biochem J 2003, 373:271-279.
45. Benet-Pages A, Orlik P, Strom TM, Lorenz-Depiereux B An FGF23 missense mutation causes familial tumor calcinosis with hyperphosphatemia. Hum Molec Genet 2005, 14:385-390.
46. Carpenter TO, Ellis TK, Insogna RL, et al. Fibroblast growth factor 7: An inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 2004, 90:1012-1020.
47. Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 2003, 278:1998-2007.
48. 2+ resorption. Science 1999, 285:103-106.
49. 2+ transport function of Claudin16. J Clin Invest 2006, 116:878-891.
50. Whyte MP Hypophosphatasia and the role of alkaline phosphatase. Endocrine Reviews 1994, 15:439-461.
51. Gunther T, Chen Z-F, Kim J, et al. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 2000, 406:199-203.
52. Maret A, Bordeaux I, Ding C, et al. Expression of GCM by intra thymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin. J Clin Endocrinol Metab 2004, 89:8-12.
53. Epstein E, Sela-Brown A, Ringel I, et al. Dynein light chain binding to a 3'-untranslated sequence mediates parathyroid hormone mRNA association with microtubules. J Clin Invest 2000, 105:505-512.
54. D'Amour P, Brossard J, Rousseau L, et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int 2005, 68:998-1007.
55. Murray TM, Rao LG, Divieti P, Bringhurst PR Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocrine Reviews 2005, 26:78-113.
56. Salusky IB, Juppner H New PTH assays and renal osteodystrophy. Pediatr Nephrol 2004, 19:709-713.
57. Cantor T, Yang Z, Caraiani N, Ilamathi E Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: Implication for treatment decisions. Clin Chem 2006, 52:1771-1776.
58. Vietri MT, Sessa M, Pilla P, et al. Serum osteocalcin and parathyroid hormone in healthy children assessed with two new automated assays. J Pediatr Endocrinol Metab 2006, 19:1413-1419.
59. Broadus AE, Nissenson RA Parathyroid hormone-related protein. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 99-106. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
60. Strewler GJ The physiology of parathyroid hormone-related protein. New Engl J Med 2000, 342:177-185.
61. Nissenson RA Editorial: Parathyroid hormone (PTH)/PTHrP receptor mutations in human chondrodysplasia. Endocrinology 1998, 139:4753-4755.
62. Miao D, He B, Karaplis AC, Goltzman D Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 2002, 109:1173-1182.
63. Henderson JE, Amizuka N, Warshawsky H, et al. Nuclear localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic death. Mol Cell Biol 1995, 15:4064-4075.
64. Kovacs CS, Chafe LL, Fudge NJ, et al. PTH regulates fetal blood calcium and skeletal mineralization independently of PTHrP. Endocrinology 2001, 142:4983-4993.
65. Buhimschi CS Endocrinology of lactation. Obstet Gynecol Clin North Am 2004, 31:963-979.
66. Sowers MF, Hollis BW, Shapiro B, et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. J Am Med Assn 1996, 276:549-554.
67. Iida-Klein A, Guo J, Takemura M, et al. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor results in selective loss of PTH-stimulated PLC activity. J Biol Chem 1997, 272:6882-6889.
68. b. Endocrinology 2006, 147:3326-3332.
69. Usdin TB, Gruber C, Bonner TI Identification and functional expression of a receptor selectively recognizing parathyroid hormone: The PTH2 receptor. J Biol Chem 1996, 270:15455-15458.
70. Deftos LJ Calcitonin. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 115-117. American Society for Bone and Mineral Research, Washington, D.C., . Sixth edition. M.J. Favus (Ed.).
71. Leboeuf R, Langlois F, Martin M, et al. "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: Case report and review of the literature. J Clin Endocrinol Metab 2006, 91:361-364.
72. Taboulet J, Frenkian M, Frendo JL, et al. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Hum Molec Genet 1998, 7:2129-2133.
73. Woodrow JP, Sharpe CJ, Fudge NJ, et al. Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 2006, 147:4010-4021.
74. Holick MF, Garabedian M Vitamin D photobiology, metabolism, mechanism of action, and clinical application. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 106-114. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
75. 3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
76. Holick MF Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006, 116:2062-2072.
77. Hollis BW, Wagner CL Nutritional vitamin D status during pregnancy: Reasons for concern. CMAJ 2006, 174:1287-1290.
78. Fu GK, Lin D, Zhang MYH, et al. Cloning of human 25-hydroxyvitamin D-1_-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Molec Endocrinol 1997, 11:1961-1970.
79. 3 1α-hydroxylase. Biochem Biophys Res Comm 1997, 239:527-533.
80. Wang JT, Lin C-J, Burridge SM, et al. Genetics of vitamin D 1α-hydroxylase deficiency in 17 families. Am J Hum Genet 1998, 63:1694-1702.
81. Overbaugh L, Stoffels K, Waer M, et al. Immune regulation of 25-hydroxyvitamin D-1α-hydroxylase in human monocytic THP1 cells: Mechanisms of interferon-a-mediated induction. J Clin Endocrinol Metab 2006, 91:3566-3574.
82. 3 1 alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1 alpha, 25(OH)2D3 in intact animals. Endocrinology 1999, 140:2224-2231.
83. Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006, 116:1703-1712.
84. Makishima M, Lu TT, Xie W, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296:1313-1316.
85. Norman AW Vitamin D receptor: New assignments for an already busy receptor. Endocrinology 2006, 147:5542-5548.
86. Root AW, Rogol AD Organization and function of the endocrine system. Principles and practice of pediatric endocrinology 2005, 3-76. Charles Thomas, Springfield, IL. M. Kappy, D. Allen, M. Geffner (Eds.).
87. 3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1α-hydroxylase and parathyroid hormone null alleles. Endocrinology 2006, 147:4801-4810.
88. Demay M Muscle: A nontraditional 1,25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions. Endocrinology 2003, 144:5135-5137.
89. Haussler MR, Haussler CA, Jurutka PW, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 1997, 154:S57-S73.
90. Nagpal S, Na S, Rathnachalam R Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews 2005, 26:662-687.
91. Malloy PJ, Pike JW, Feldman D The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocrine Reviews 1999, 20:156-188.
92. Gilad LA, Bresler T, Gnainsky J, et al. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 2005, 185:577-592.
93. Wood RJ, Fleet JC The genetics of osteoporosis: Vitamin D receptor polymorphisms. Ann Rev Nutr 1998, 18:233-258.
94. Tao C, Yu T, Garnett S, et al. Vitamin D receptor alleles predict growth and bone density in girls. Arch Dis Child 1998, 79:488-494.
95. Lorentzon M, Lorentzon R, Nordstrom P Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: A cross-sectional and longitudinal study. J Clin Endocrinol Metab 2000, 85:1666-1671.
96. Xiong D-H, Xu FH, Liu P-Y, et al. Vitamin D receptor gene polymorphisms are linked to and associated with adult height. J Med Genet 2005, 42:228-234.
97. Kitagawa H, Fujiki R, Yoshimura K, et al. The chromatin-remodel complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 2003, 113:905-917.
98. Li YC, Pirro AE, Amling M, et al. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997, 94:9831-9835.
99. Amling M, Priemel M, Holzmann T, et al. Rescue of skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: Formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140:4982-4987.
100. Yagishita N, Yamamoto Y, Yoshizawa T, et al. Aberrant growth plate development in VDR/RXR double null mutant mice. Endocrinology 2001, 142:5332-5341.
101. Rummens K, Van Cromphaut SJ, Carmeliet G, et al. Pregnancy in mice lacking the vitamin D receptor: Normal maternal skeletal response, but fetal hypomineralization rescued by maternal calcium supplementation. Pediatr Res 2003, 54:466-473.
102. Fleet JC Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: What are they and what do they mean?. J Nutrition 2004, 134:3215-3218.
103. Norman AW, Mizwicki MT, Norman DP Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004, 3:21-41.
104. 3 and peroxisome proliferator-activated receptor (PPAR) gamma ligand target protein that regulates PPAR gamma signaling. Endocrinology 2006, 147:733-743.
105. 3 in vivo and in vitro. Mol Endocrinol 2004, 18:2660-2671.
106. Boyan BD, Schwartz Z Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and bone. Steroids 2004, 69:591-597.
107. Peng L, Malloy PJ, Feldman D Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol Endocrinol 2004, 18:1109-1119.
108. Pedrozo HA, Schwartz Z, Rimes S, et al. Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25(O)2D3. J Bone Miner Res 1999, 14:856-857.
109. Baron R Anatomy and ultrastructure of bone. Primer on the metabolic bone diseases and disorders of mineral metabolism 1999, 3-10. Lippincott Williams & Wilkins, Philadelphia. Fourth edition. M. Favus (Ed.).
110. Cohen MM The new bone biology: Pathologic, molecular, and clinical studies. Am J Med Genet 2006, 140A:2646-2706.
111. Dempster DW Anatomy and function of the adult skeleton. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 7-11. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
112. Aubin JE, Lian JB, Stein GB Bone formation: Maturation and functional activities of osteoblast lineage cells. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 20-29. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
113. Kaplan FS, Fiori J, Serrano de la Pena L, et al. Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva. Ann NY Acad Sci 2006, 1068:54-65.
114. Kronenberg HM Developmental regulation of the growth plate. Nature 2003, 423:332-336.
115. Karsenty G The complexities of skeletal biology. Nature 2003, 423:316-318.
116. Olsen BR Bone embryology. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 2-6. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
117. Nelson WJ, Nusse R Convergence of Wnt, b-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
118. Ott SM Sclerostin and Wnt signaling: The pathway to bone strength. J Clin Endocrinol Metab 2005, 90:6741-6743.
119. James MJ, Jarvinen E, Wang X-P, Thesleff I Different roles of Runx2 during early neural crest-derived bone and tooth development. J Bone Miner Res 2006, 21:1034-1044.
120. Hill TP, Spater D, Taketo MM, et al. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
121. Zelzer E, Olsen BR Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Topics Dev Biol 2005, 65:169-187.
122. Bamshad M, Watkins WS, Dixon ME, et al. Reconstructing the history of human limb development: Lessons from birth defects. Pediatr Res 1999, 45:291-299.
123. Marglies EH, Innis JW Building arms or legs with molecular models. Pediatr Res 2000, 47:2-3.
124. Thiel CT, Horn D, Zabel B, et al. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet 2005, 77:795-806.
125. De Luca F Impaired growth plate chondrogenesis in children with chronic illness. Pediatr Res 2006, 59:625-629.
126. Robson H, Siebler T, Shalet SM, Williams GR Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth. Pediatr Res 2003, 52:137-147.
127. Kobayashi T, Soegiarto DW, Yang Y, et al. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 2005, 115:1734-1742.
128. Huang W, Chung U, Kronenberg HM, de Crombrugghe B The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Nat Acad Sci 2001, 98:160-165.
129. Lanske B, Karalis AC, Lee K, et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996, 273:663-666.
130. Backesjo C-M, Li Y, Lindgren U, Haldosen L-A Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 2006, 21:993-1002.
131. Ducy P, Schinke T, Karsenty G The osteoblast: A sophisticated fibroblast under central surveillance. Science 2000, 289:1501-1504.
132. Manolagas SC Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews 2000, 21:115-137.
133. Robey PG, Boskey AL Extracellular matrix and biomineralization of bone. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 12-19. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
134. Suda T, Takahashi N, Udagawa N, et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Reviews 1999, 20:345-357.
135. Bilezikian JP What's good for the goose's skeleton is good for the gander's skeleton. J Clin Endocrinol Metab 2006, 91:1223-1225.
136. Vanderschueren D, Venken K, Ophoff J, et al. Sex steroids and the periosteum: Reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 2006, 91:378-382.
137. Bickle DB, Sakata T, Leary C, et al. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 2002, 17:1570-1578.
138. Fukushima N, Hanada R, Teranishi H, et al. Ghrelin directly regulates bone formation. J Bone Miner Res 2004, 20:790-798.
139. Rogers A, Eastell R Circulating osteoprotegerin and receptor activator for nuclear factor kB ligand: Clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005, 90:6323-6331.
140. Ross FP Osteoclast biology and bone resorption. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 30-35. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
141. Teitelbaum SL Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
142. Okamoto M, Murai J, Yoshikawa H, Tsumaloi N Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 2006, 21:1022-1033.
143. Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Min Res 2000, 15:2-12.
144. Whyte MP, Obrecht SE, Finnegan PM, et al. Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 2002, 347:175-184.
145. Takayangi H, Kim S, Matsuo K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-B. Nature 2002, 416:744-749.
146. Karin M Nuclear factor-kB in cancer development and progression. Nature 2006, 441:431-436.
147. Byers PH Disorders of collagen biosynthesis and structure. The metabolic and molecular bases of inherited disease 1995, 4029-4077. McGraw-Hill, New York. Seventh edition. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Vale (Eds.).
148. Garnero P, Delmas PD Biochemical markers of bone turnover: Applications for osteoporosis. Endocrinol Metab Clin NA 1998, 27:303-323.
149. Barnes AM, Chang W, Morello R, et al. Deficiency of cartilage-associated protein in lethal osteogenesis imperfecta. N Engl J Med 2006, 355:2757-2764.
150. Cabral WA, Chang W, Barnes AM, et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nature Genet 2007, 39:359-365.
151. Morello R, Bertin TK, Chen Y, et al. CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006, 127:291-304.
152. Yamaga A, Taga M, Hashimoto S, Ota C Comparison of bone metabolic markers between maternal and cord blood. Horm Res 1999, 51:277-279.
153. Seibold-Weiger K, Wollmann HA, Ranke MB, Speer CP Plasma concentrations of the carboxyterminal propeptide of type I procollagen (PICP) in preterm neonates from birth to term. Pediatr Res 2000, 48:104-108.
154. Naylor KE, Eastell R, Shattuck KE, et al. Bone turnover in premature infants. Pediatr Res 1999, 45:363-366.
155. Bollen A-M, Eyre DR Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 1994, 15:31-34.
156. Crofton PM, Wade JC, Taylor MRH, Holland CV Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxy-terminal telopeptide of type I collagen, and their interrelationships in school children. Clin Chem 1997, 43:1577-1581.
157. Hussain SM, Mughal Z, Williams G, et al. Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds. Arch Dis Child 1999, 80:370-373.
158. Mora S, Pitukcheewanont P, Kaufman FR, et al. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 1999, 14:1664-1671.
159. Sorva R, Anttila R, Siimes MA, et al. Serum markers of collagen metabolism and serum osteocalcin in relation to pubertal development in 57 boys at 14 years of age. Pediatr Res 1997, 42:528-532.
160. Tobiume H, Kanzaki S, Hida S, et al. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: A potential marker for bone formation and response to GH therapy. J Clin Endocrinol Metab 1997, 82:2056-2061.
161. Zittermann A, Scwarz I, Scheld K, et al. Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women. J Clin Endocrinol Metab 2000, 85:95-101.
162. Schinke T, McKee MD, Karsenty G Extracellular matrix calcification: Where is the action?. Nature Genet 1999, 21:150-151.
163. Gericke A, Qin C, Spevak L, et al. Importance of phosphorylation for osteopontin regulation of biomineralization. Calc Tiss Int 2005, 77:45-54.
164. Chavassieux P, Seeman E, Delmas PD Insights into material and structural basis of bone fragility from diseases associated with fractures: How determinants of the biomechanical properties of bone are compromised by disease. Endocrine Reviews 2007, 28:151-164.
165. Rubin C, Rubin J Biomechanics and mechanobiology of bone. Primer on the metabolic Bone Diseases and Disorders of Mineral Metabolism 2006, 36-42. American Society for Bone and Mineral Research, Washington, D.C., 2006. 6 th ed. M.J. Favus (Ed.).
166. Frost HM, Schonau E The "muscle-bone unit" in children and adolescents: A 2000 overview. J Pediatr Endocrinol Metab 2000, 13:571-590.
167. Rauch F Material matters: a mechanostat-based perspective on bone development in osteogenesis imperfecta and hypophosphatemic rickets. J Musculoskelet Neuronal Interact 2006, 6:142-146.
168. Hughes-Fulford M Signal transduction and mechanical stress. Sci STKE 2004, 2004:re12.
169. Salingcarnboriboon R, Tsuji K, Komori T, et al. Runx2 is a target of mechanical unloading to alter osteoblastic activity and bone formation in vivo. Endocrinology 2006, 147:2296-2305.
170. Specker L, Schonau E Quantitative bone analysis in children: Current methods and recommendations. J Pediatr 2005, 146:726-731.
171. Rigo J, De Curtis M, Pieltain C, et al. Bone mineral metabolism in the micropremie. Clin Perinatol 2000, 27:147-170.
172. Bailey DA, McKay HA, Mirwald RL, et al. A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: The University of Saskatchewan bone mineral accrual study. J Bone Miner Res 1999, 14:1672-1679.
173. Bonjour J-P, Carrie A-L, Ferrari S, et al. Calcium-enriched foods and bone mass growth in prepubertal girls: A randomized, double-blind, placebo-controlled trial. J Clin Invest 1997, 99:1287-1294.
174. Winzenberg TM, Shaw K, Fryer J, Jones G Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ 2006, 333:775-778.
175. Greenfield EM, Goldberg VM Genetic determination of bone density. Lancet 1997, 350:1254-1263.
176. Liu Y-J, Shen H, Xiao P, et al. Molecular genetic studies of gene identification for osteoporosis, A 2004 update. J Bone Miner Res 2005, 21:1511-1535.
177. Bachrach LK, Hastie T, Wang M-C, et al. Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: A longitudinal study. J Clin Endocrinol Metab 1999, 84:4702-4712.
178. Rubin K, Schirduan V, Gendreau P, et al. Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty. J Pediatr 1993, 123:863-870.
179. Rubin LA, Hawker GA, Peltekova V, et al. Determinants of peak bone mass: Clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 1999, 14:633-643.
180. Weaver CM, Peacock M, Johnston CC Adolescent nutrition in the prevention of postmenopausal osteoporosis. J Clin Endocrinol Metab 1999, 84:1839-1843.
181. Bradney M, Pearce G, Sullivan C, et al. Moderate exercise during growth in prepubertal boys: Changes in bone mass, size volumetric density and bone strength: A controlled prospective study. J Bone Miner Res 1998, 13:1814-1821.
182. Morris FL, Naughton GA, Gibbs JL, et al. Prospective 10-month exercise intervention in premenarchal girls: positive effects on bone and lean mass. J Bone Miner Res 1997, 12:1453-1462.
183. Lehtonen-M, Mottonen T, Irjala K, et al. A 1-year prospective study on the relationship between physical activity, markers of bone metabolism, and bone acquisition in peripubertal girls. J Clin Endocrinol Metab 2000, 85:3726-3732.
184. Morel J, Combe B, Francisco J, Bernard J Bone mineral density of 704 amateur sportsman involved in different physical activities. Osteoporosis Int 2001, 12:152-157.
185. Van der Eerden BCJ, Karperien M, Wit J Systemic and local regulation of the growth plate. Endocrine Reviews 2003, 24:782-801.
186. Wang Y, Nishida S, Sakata T, et al. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology 2006, 147:4753-4761.
187. Cruickshank J, Grossman DI, Peng RK, et al. Spatial distribution of growth hormone receptor, insulin-like growth factor-1 receptor and apoptotic chondrocytes during growth plate development. J Endocrinol 2005, 184:543-553.
188. Rosenfeld R Molecular mechanisms of IGF-I deficiency. Horm Res 2006, 65(1):15-20.
189. Cohen P Overview of the IGF-I system. Horm Res 2006, 65(1):3-8.
190. Yakar S, Liu J-L, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor-I. Proc Natl Acad Sci 1999, 96:7324-7329.
191. Savage MO, Attie KM, David A, et al. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity. Nature Clin Prac Endocrin Metab 2006, 2:395-407.
192. Caminos JE, Gualillo O, Lago F, et al. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 2005, 146:1285-1292.
193. Ohlsson C, Bengtsson B-A, Isaksson OGP, et al. Growth hormone and bone. Endocrine Reviews 1998, 19:55-79.
194. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab 1998, 83:3150-3154.
195. Bachrach LK, Marcus R, Ott SM, et al. Bone mineral histomorphometry and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res 1998, 13:415-421.
196. Woods KA, Camacho-Huber C, Bergman RN, et al. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 2000, 85:1407-1411.
197. Barnard JC, Williams AJ, Rabier B, et al. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology 2005, 146:5568-5580.
198. Rauch F, Bailey DA, Baxter-Jones A, et al. The "muscle-bone unit" during the pubertal growth spurt. Bone 2004, 34:771-775.
199. Couse JF, Korach KS Estrogen receptor null mice: What have we learned and where will they lead us?. Endocrine Reviews 1999, 20:358-417.
200. Marcus R, Leary C, Schneider DL, et al. The contribution of testosterone to skeletal development and maintenance: Lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2000, 85:1032-1037.
201. Vanderschueren D, Bouillon R Androgens and bone. Calcif Tissue Int 1995, 56:341-346.
202. Libanati C, Baylink DJ, Lois-Wenzel E, et al. Studies on potential mediators of skeletal changes occurring during puberty in girls. J Clin Endocrinol Metab 1999, 84:2807-2814.
203. Martin TJ, Gaddy D Bone loss goes beyond estrogen. Nature Med 2006, 12:612-613.
204. Perrien DS, Akel NS, Edwards PK, et al. Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 2007, 148:1654-1665.
205. Potter LR, Abbey-Hosch A, Dickey DM Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews 2006, 27:47-72.
206. Prickett TMCR, Lynne AM, Barrell GK, et al. Amino-terminal proCNP: A putative marker of cartilage activity in post natal growth. Pediatr Res 2005, 58:334-340.
207. Bartels CF, Bukulmez H, Padayatti P, et al. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maoteaux. Am J Hum Genet 2004, 75:27-34.
208. Janicka A, Wren TAL, Sanchez MM, et al. Fat mass is not beneficial to bone in adolescents and young adults. J Clin Endocrinol Metab 2007, 92:143-147.
209. Thomas T, Gori F, Khosla S, et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140:1630-1638.
210. Klein KO, Larmore KA, de Lancey E, et al. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 1998, 83:3469-3475.
211. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 2000, 100:197-207.
212. Pogoda P, Egermann M, Schnell JC, et al. Leptin inhibits bone formation not only in rodents but also in sheep. J Bone Miner Res 2006, 21:1591-1599.
213. Baldock PA, Allison S, McDonald MM, et al. Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 2006, 21:1600-1607.
214. Luo X-H, Guo L-J, Xie H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006, 21:1648-1656.
215. Glorieux FH, Travers R, Taylor A, et al. Normative data for iliac bone histomorphometry in growing children. Bone 2000, 26:103-109.
216. Rauch F Watching bones at work: What we can see from bone biopsies. Pediatr Nephrol 2006, 21:457-462.
217. Recker RR, Barger-Lux MJ Bone biopsy and histomorphometry in clinical practice. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 161-169. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
218. Bachrach LK Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin N Am 2005, 34:521-535.
219. Koo WWK, Hammami M, Hockman EM Validation of bone mass and body composition measurements in small subjects with pencil beam dual energy x-ray absorptiometry. J Am Coll Nutr 2004, 23:79-84.
220. Hammami M, Koo WW, Hockman EM Body composition of neonates from fan beam dual energy x-ray absorptiometry measurement. J Parenteral Enteral Nutr 2003, 27:423-426.
221. Leonard MB, Propert KJ, Zemel BS, et al. Discrepancies in pediatric bone mineral density reference data: Potential for misdiagnosis of osteopenia. J Pediatr 1999, 135:182-188.
222. Seeman E Growth in bone mass and size: Are racial and gender differences in bone mineral density more apparent than real?. J Clin Endocrinol Metab 1998, 83:1414-1419.
223. Ward KA, Ashby RL, Roberts SA, et al. UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch Dis Child 2007, 92:53-59.
224. Lu PW, Cowell CT, Lloyd-Jones SA, et al. Volumetric bone mineral density in normal subjects aged 5-27 years. J Clin Endocrinol Metab 1996, 81:1586-1590.
225. Gilsanz V, Skaggs DL, Kovanlikaya A, et al. Differential effects of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab 1998, 83:1420-1427.
226. Miller PD, Leonard MB Clinical use of bone mass measurements in children and adults for the assessment and management of osteoporosis. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 150-161. American Society for Bone and Mineral Research, Washington, D.C. Sixth edition. M.J. Favus (Ed.).
227. Brismar TB, Lindgren A-C, Ringertz H, et al. Total bone mineral measurements in children with Prader-Willi syndrome: The influence of the skull's bone mineral content per area (BMA) and of height. Pediatr Radiol 1998, 28:38-42.
228. Maynard LM, Guo SS, Chumlea WC, et al. Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y; the Fels Longitudinal Study. Am J Clin Nutr 1998, 68:1111-1117.
229. Koo WWK Body composition measurements during infancy. NY Acad Sci 2000, 904:383-392.
230. Koo WWK, Walters J, Bush AJ, et al. Dual-energy x-ray absorptiometry studies of bone mineral status in newborn infants. J Bone Miner Res 1996, 11:997-1002.
231. Lapillone A, Braillon P, Claris O, et al. Body composition in appropriate and in small for gestational age infants. Acta Paediatr 1997, 86:196-200.
232. Weiler HA, Yuen CK, Seshia MM Growth and bone mineralization of young adults weighing less than 1500 grams at birth. Early Hum Devel 2002, 67:101-112.
233. Yeste D, Aslmar J, Clemente M, et al. Areal bone mineral density of the lumbar spine in 80 premature newborns. A prospective and longitudinal study. J Pediatr Endocrinol Metab 2004, 17:959-966.
234. Hammami M, Koo WW, Hockman EM Technical considerations for fan-beam dual-energy x-ray absorptiometry body composition studies in pediatric studies. J Parenteral Enteral Nutr 2004, 28:328-333.
235. Koo WW, Hockman EM, Hammami M Dual energy X-ray absorptiometry measurements in small subjects: conditions affecting clinical measurements. J Am Coll Nutr 2004, 23:212-219.
236. Boot AM, de Ridder MA, Pols HA, et al. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab 1997, 82:57-62.
237. Molgaard C, Thomsen BL, Prentice A, et al. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997, 76:9-15.
238. Zemel BS, Leonard MB, Kalkwarf HJ, et al. Reference data for whole body, lumbar spine and proximal femur for American children relative to age, gender and body size. J Bone Miner Res 2004, 19(1):S231.
239. del Rio L, Carrascosa A, Pons F, et al. Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: Changes related to age, sex, and puberty. Pediatr Res 1994, 35:362-366.
240. Kroger H, Kotaniemi A, Kroger L, Alhava E Development of bone mass and bone density of the spine and femoral neck: A prospective study of 65 children and adolescents. Bone Mineral 1993, 23:171-182.
241. McKay HA, Bailey DA, Mirwald RL, et al. Peak bone mineral accrual and age at menarche in adolescent girls: A 6-year longitudinal study. J Pediatr 1998, 133:682-687.
242. Takahashi Y, Minamitani K, Kobayashi Y, et al. Spinal and femoral bone mass accumulation during normal adolescence: Comparison with female patients with sexual precocity and with hypogonadism. J Clin Endocrinol Metab 1996, 81:1248-1253.
243. Finkelstein JS, Neer RM, Biller BMK, et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992, 326:600-604.
244. Wren TALH, Liu X, Pitukcheewanont P, Gilsanz V Bone densitometry in pediatric patients: Discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr 2005, 146:776-779.
245. Neu CM, Rauch F, Manz F, Schonau E Modeling of cross-sectional bone size, mass and geometry at the proximal radius: A study of normal bone development using peripheral quantitative computed tomography. Osteoporos Int 2001, 12:538-547.
246. Neu CM, Manz F, Rauch F, et al. Bone densities and bone size at the distal radius in healthy children and adolescents: A study using peripheral quantitative computed tomography. Bone 2001, 28:227-232.
247. Rauch F, Schonau E Peripheral quantitative computed tomography of the distal radius in young subjects: New reference data and interpretation of results. J Musculoskelet Neuronal Interact 2005, 5:119-126.
248. Leonard MB, Shults J, Justine E, et al. Interpretation of whole body dual energy X-ray absorptiometry measures in children: Comparison with peripheral quantitative computed tomography. Bone 2004, 34:1044-1052.
249. Zadik Z, Price D, Diamond G Pediatric reference curves for multi-site quantitative ultrasound and its modulators. Osteoporos Int 2003, 14:857-862.
250. Baroncelli GI, Federico G, Vignolo M, et al. Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development. Bone 2006, 39:159-173.
251. Ashmeade T, Pereda L, Chen, Carver JD Longitudinal measurements of bone status in preterm infants. J Pediatr Endocrinol Metab 2007, 20:415-424.
252. Fielding KT, Nix DA, Bachrach LK Comparison of calcaneus ultrasound and dual x-ray absorptiometry in children at risk of osteopenia. J Clin Densit 2003, 6:7-15.
253. Fricke O, Tutlewski B, Schwahn B, Schoenau E Speed of sound: Relation to geometric characteristics of bone in children, adolescents, and adults. J Pediatr 2005, 146:764-768.
254. Loud KJ, Gordon CM Adolescent bone health. Arch Pediatr Adolesc Med 2006, 160:1026-1032.
255. American Academy of Pediatrics Calcium requirements of infants, children, and adolescents. Pediatrics 1999, 104:1152-1157.
256. Hertel NT, Stoltenberg M, Juul A, et al. Serum concentrations of Type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate. J Clin Endocrinol Metab 1993, 76:924-927.
257. Koo WWK, Bush AJ, Walters J, Carlson SE Postnatal development of bone mineral status during infancy. J Am Coll Nutr 1998, 17:65-70.
258. Zaidi M Skeletal remodeling in health and disease. Nature Med 2007, 13:791-801.
259. Kalkwarf HJ, Zemel BS, Gilsanz V, et al. The bone mineral density in childhood study: Bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 2007, 92:2087-2099.